Company: GNMSF
Filing Date: 2025-02-12
Form Type: 20-F
Source: 0001558370-25-000846
Chunk: 112

Company: GENMAB A/S
Filing Date: 2025-02-12
Form: 20-F
Item: Item 6
Chunk 112
---
510   ​                                1,598
Chief Commercial Officer**                               ​                    ​         ​   ​                                    ​
​                                                        ​                    ​         ​   ​                                    ​
* – Anthony Mancini stepped down as Chief Operating Officer in August 2024.
** – Brad Bailey and Rayne Waller were appointed Executive Vice President and Chief Commercial Officer, and Executive Vice President and Chief Technical Operations Officer, respectively, and members of the Executive Management in August 2024.
​
Insurance and Discharge of Liability
According to the DCA, shareholders, at the general meeting, are permitted to discharge our Board members and registered managers from liability for any particular financial year based on a resolution relating to the period covered by the Audited Financial Statements for the previous financial year. This discharge means that the shareholders will relieve such Board members and registered managers from liability to us. However, shareholders cannot discharge any claims by individual shareholders or other third parties. In addition, the discharge can be set aside in case the general meeting prior to its decision to discharge was not presented with all reasonable information necessary for the general meeting to assess the matter at hand.

88

In addition, we provide our Board members and registered managers with directors’ and officers’ liability insurance, and have, similar to other Danish larger companies, implemented an indemnification scheme adopted during the 2024 Annual General Meeting that, in certain cases, covers the liability that Board members, registered managers and/or managerial employees may incur while acting in their capacities as such.
We have not granted any loans, guarantees, or other commitments to or on behalf of any members of our Board of Directors or Executive Management.
Employment Agreement and Warrant Grants
We have entered into employment agreements with, and issued RSUs and warrants to, our Executive Management. See “—Compensation—Certain Executive Management Agreements” and “—Compensation—Warrant Program” and “—Compensation—Restricted Stock Unit Program” for more information.
C.   Board Practices
Board of Directors
The Board plays an active role in setting our strategies and goals and monitoring our operations and results. Board duties include establishing policies for strategy, accounting, organization and finance and the appointment of the Company’s registered managers. The Board also assesses our capital and share structure and is responsible for approving share issues and the grant of warrants and RSUs. In addition, the Board ensures that our affairs are managed in accordance with our articles of association and applicable law.
The Board performs its duties in accordance with the rules of procedure of the